Angiotensin-II administration is useful for the detection of liver metastasis from pancreatic cancer during pharmacoangiographic computed tomography

doi:10.3748/wjg.v13.i22.3080

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 22

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1561)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

178

HTML

1217

Figures (1-3)

166

Sum=1561

Jun 14, 2007 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jun 14, 2007; 13(22): 3080-3083
Published online Jun 14, 2007. doi: 10.3748/wjg.v13.i22.3080

Full Size Figure Download Figure

Figure 3 Tumor to liver parenchyma contrast in angiographic CT with and without angiotensin II (AT-II) in 35 patients with liver metastasis due to pancreatic cancer.

Citation: Ishikawa T, Ushiki T, Kamimura H, Togashi T, Tsuchiya A, Watanabe K, Seki KI, Ohta H, Yoshida T, Takeda K, Kamimura T. Angiotensin-II administration is useful for the detection of liver metastasis from pancreatic cancer during pharmacoangiographic computed tomography. World J Gastroenterol 2007; 13(22): 3080-3083
URL: https://www.wjgnet.com/1007-9327/full/v13/i22/3080.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i22.3080